Pharmaceutical giant Smith-Kline Beecham has appointed GCI Prague
to promote its consumer healthcare brands, which cover oral care and OTC
medicines, in the Czech Republic. GCI is understood to have pitched
against Ogilvy and Mather and Burson-Marsteller for the work.
PR for the company’s consumer healthcare division was previously split
between GCI and O&M, with GCI promoting the toothpaste Aquafresh, Oxy
skin care products and flu treatment Coldrex; and O&M handling brands
including Panadol and other analgesics, which GCI will now take on.
GCI’s brief also encompasses product PR for new OTC and oral care brands
to be launched this autumn and corporate PR for the company’s consumer
healthcare division, including communicating with pharmacists,
professional institutions and regulatory bodies.
’This means recognition of our past work, and will help us explore the
healthcare sector,’ said Katka Wheeler, GCI’s regional director for
central and eastern Europe.